Top Markets
#1 Verus Coin Verus Coin +22.50%
#2 Ontology Gas Ontology Gas +22.29%
#3 EXOD EXOD +22.08%
#4 Status Status +19.09%
#5 ETHGas ETHGas +16.12%
#6 Geodnet Geodnet +14.72%
#7 Curve DAO Curve DAO +12.57%
#8 Derive Derive +11.77%
#9 The Black Bull The Black Bull +11.67%
#10 Bitway Bitway +11.10%
Coin of the day
Verus Coin Verus Coin
設定
言語
日本
通貨
USD
テーマ
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
株式のランク #25502
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
株価
$1.34
最終同期: 2024-02-14
時価総額
$48.96M
変化（1日）
-12.94%
変化（1年）
0.00%
国
SE
取引 Promore Pharma AB (publ) (PROMO)

カテゴリー

Healthcare
Promore Pharma AB (publ)（PROMO）の配当履歴
Promore Pharma AB (publ)（証券コード：PROMO）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのPromore Pharma AB (publ)（PROMO）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US